Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

As the world experiences accelerated change in technology and consumer preferences, the South African automotive industry has to embrace profound transformation to maintain its heritage of ...

(9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 ...

Wuthering Waves has released the second phase of its version 2.4 update featuring the Flames of Heart quest alongside a new 5 ...

Star. The Mariners’ catcher won Phase 2 of the PRO SPIRIT MLB All-Star Ballot that closed on Wednesday morning over Toronto’s ...

Council members spent most of the day behind closed doors in executive session, but spent the final hour questioning officials about the potential impact of the legislation.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...

FORT WAYNE, Ind. (WPTA) - Starting July 8th the Bluffton Rd. bridge will be reduced down to one lane, meaning longer delays ...

One-third of this year's National League All-Star starting nine will be wearing Dodger blue. Will Smith and Freddie Freeman ...

Detroit Tigers 2B Gleyber Torres beat out Baltimore's Jackson Holliday in Phase 2 voting, awarding him a starting spot in the ...

Baseball's stars shine the brightest at the Midsummer Classic every season, and this year will be no different.